Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Regenxbio (RGNX) over the last 10 years, with Q3 2025 value amounting to $82.2 million.

  • Regenxbio's Change in Acquisitions & Divestments fell 523.73% to $82.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.0 million, marking a year-over-year decrease of 757.6%. This contributed to the annual value of $290.2 million for FY2024, which is 166.24% up from last year.
  • Latest data reveals that Regenxbio reported Change in Acquisitions & Divestments of $82.2 million as of Q3 2025, which was down 523.73% from $71.1 million recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Change in Acquisitions & Divestments registered a high of $107.6 million during Q2 2023, and its lowest value of $33.7 million during Q4 2021.
  • Its 5-year average for Change in Acquisitions & Divestments is $61.4 million, with a median of $56.3 million in 2023.
  • Per our database at Business Quant, Regenxbio's Change in Acquisitions & Divestments tumbled by 5786.23% in 2021 and then soared by 19054.82% in 2023.
  • Over the past 5 years, Regenxbio's Change in Acquisitions & Divestments (Quarter) stood at $33.7 million in 2021, then soared by 30.96% to $44.1 million in 2022, then rose by 21.76% to $53.7 million in 2023, then fell by 3.62% to $51.8 million in 2024, then soared by 58.78% to $82.2 million in 2025.
  • Its last three reported values are $82.2 million in Q3 2025, $71.1 million for Q2 2025, and $64.9 million during Q1 2025.